Annovis Bio Inc (ANVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Operating Expenses | 29,695 | 26,695 | 45,035 | 25,511 | 14,537 |
| Operating Income | -29,695 | -26,695 | -45,035 | -25,511 | -14,537 |
| Other Income | 841 | 2,105 | -11,169 | 183 | 50 |
| Pre-tax Income | -28,854 | -24,590 | -56,204 | -25,329 | -14,487 |
| Net Income Continuous | -28,854 | -24,590 | -56,204 | -25,329 | -14,487 |
| Net Income | $-28,854 | $-24,590 | $-56,204 | $-25,329 | $-14,487 |
| EPS Basic Total Ops | -1.40 | -2.02 | -6.23 | -3.10 | -1.90 |
| EPS Basic Continuous Ops | -1.40 | -2.02 | -6.23 | -3.10 | -1.90 |
| EPS Diluted Total Ops | -1.40 | -2.31 | -6.23 | -3.10 | -1.90 |
| EPS Diluted Continuous Ops | -1.40 | -2.01 | -6.23 | -3.10 | -1.90 |
| EPS Diluted Before Non-Recurring Items | N/A | -2.31 | -4.92 | -3.10 | -1.90 |
| EBITDA(a) | $-29,695 | $-26,695 | $-45,035 | $-25,511 | $-14,537 |